Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
Open accessAbstract
Insulin resistance and hyperandrogenemia observed in polycystic ovary syndrome (PCOS) are associated with metabolic disturbances and could be connected with body composition pattern. To date, several studies defining the parameters of body composition using dual energy X-ray absorptiometry (DXA) method in the group of PCOS patients have been published, however, without the analysis in different phenotypes. The aim of the present study was to investigate the relationships between serum androgens concentration, insulin resistance and distribution of fat mass using DXA method in various PCOS phenotypes according to the Rotterdam criteria. We examined 146 women: 34 (38%) had PCOS phenotype A, 20 (23%) phenotype B, 20 (23%) phenotype C and 15 (16%) phenotype D (with mean age of each phenotype 25 years), and 57 control subjects (mean age of 25.5 years). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. Serum concentrations of testosterone, androstenedione and dehydroepiandrosterone sulfate (DHEA-S) were assessed and free androgen index (FAI) was calculated. In phenotypes A, B and C, we observed higher FAI in comparison to the control group (all p < 0.01). Serum concentrations of androstenedione and DHEA-S were higher in phenotypes A and C in comparison to the control group (all p < 0.01). However, only in phenotype A we found higher visceral adipose tissue (VAT) mass and android/gynoid ratio (A/G ratio) in comparison to the control group (all p < 0.01). In phenotype A, we observed connection of VAT with FAI (r = 0.58, p < 0.01). Accordingly, A/G ratio was related with FAI in all phenotypes (all p < 0.05). Additionally, in phenotype C, A/G ratio was related to serum concentrations of DHEA-S and androstenedione (r = 0.46, p = 0.03; r = 0.53, p = 0.01, respectively). We also found connections of HOMA-IR with VAT and A/G ratio in all phenotypes (all p < 0.05). Women with phenotype A had higher amount of VAT and A/G ratio in comparison to the control group. Serum concentration of androgens and insulin resistance are connected with VAT and A/G ratio in normoandrogenic and hyperandrogenic PCOS phenotypes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Excessive energy intake and high androgen levels promote a change in body fat distribution with an increase in visceral fat volume.
“It is influenced by many factors, including excessive energy intake and high androgen levels that promote a change in body fat distribution with an increase in visceral fat volume [9,36].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [9]
Increased adipose tissue volume, especially visceral adipose tissue, plays an important role in the development of insulin resistance.
“Increased adipose tissue volume, especially visceral adipose tissue, plays an important role in IR development [9].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [9]
Androgen excess by favoring visceral adiposity contributes to insulin resistance (IR) and to the development of hyperinsulinism.
“Androgen excess by favoring visceral adiposity contributes to insulin resistance (IR) and to the development of hyperinsulinism [9].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · see citing works
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · see citing works
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113 · see citing works
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · see citing works
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,761 · see citing works
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · see citing works
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,884 · see citing works
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · see citing works
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2153 · Cited by 434 · see citing works
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317 · see citing works
Kirchengast, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1255 · Cited by 291 · see citing works
O’Reilly, M., TAYLOR, A. E. R., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 279 · see citing works
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262 · see citing works
Legro, R. S., Bentley–Lewis, R., Driscoll, D. A., Wang, S. C., & Dunaif, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8513 · Cited by 222 · see citing works
Medical implications of ultrasonically detected polycystic ovaries
Swanson, M. K., Sauerbrei, E. E., & Cooperberg, P. L. (1981) · Journal of Clinical Ultrasound · doi:10.1002/jcu.1870090504 · Cited by 218 · see citing works
Park, Y.-W., Heymsfield, S., & Gallagher, D. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801982 · Cited by 196 · see citing works
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A. M., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166 · see citing works
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135 · see citing works
Wiltgen, D., & Spritzer, P. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.015 · Cited by 105 · see citing works
Mari, A., Pacini, G., Brazzale, A. R., & Ahr�n, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1683-9 · Cited by 105 · see citing works
Iron metabolism and the polycystic ovary syndrome
Escobar-Morreale, H. F. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.003 · Cited by 105 · see citing works
Carmina, E., Bucchieri, S., Mansueto, P., Rini, G., Ferin, M., & Løbo, R. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.007 · Cited by 103 · see citing works
Clark, N. M., Podolski, A. J., Brooks, E. D., Chizen, D. R., Pierson, R. A., Lehotay, D. C., & Lujan, M. E. (2014) · Reproductive Sciences · doi:10.1177/1933719114522525 · Cited by 103 · see citing works
Assessment of insulin secretion in relation to insulin resistance
Mari, A., Åhrén, B., & Pacini, G. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171130.23441.59 · Cited by 87 · see citing works
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73 · see citing works
Yilmaz, M., İsaoğlu, Ü., Delibaş, İ. B., & Kadanalı, S. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01478.x · Cited by 71 · see citing works
Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome
Wehr, E., Möller, R., Horejsi, R., Giuliani, A., Kopera, D., Schweighofer, N., Groselj‐Strele, A., Pieber, T. R., & Obermayer-Pietsch, B. M. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1162-2 · Cited by 64 · see citing works
Yücel, A., Noyan, V., & Sağsöz, N. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.11.012 · Cited by 61 · see citing works
Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
Jacewicz‐Święcka, M., & Kowalska, I. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3054 · Cited by 38 · see citing works
Self-citationKozakowski, J., & Zgliczyński, W. (2013) · PubMed · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408 · see citing works
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148 · see citing works
Zhang, H., Wang, W., Zhao, J., Jiao, P., Zeng, L., Zhang, H., Zhao, Y., Shi, L., Hu, H., Luo, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1085656 · Cited by 71 · see citing works
Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome
Krentowska, A., & Kowalska, I. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3464 · Cited by 56 · see citing works
Self-citationMukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 52 · see citing works
Borzan, V., Lerchbaum, E., Missbrenner, C., Heijboer, A. C., Goschnik, M., Trummer, C., Theiler‐Schwetz, V., Haudum, C. W., Gumpold, R., Schweighofer, N., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040829 · Cited by 45 · see citing works
Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697223 · Cited by 41 · see citing works
Rambaran, N., & Islam, M. S. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.108789 · Cited by 41 · see citing works
Feyzioğlu, B. S., Güven, C. M., & Avul, Z. (2023) · Nutrients · doi:10.3390/nu15102260 · Cited by 31 · see citing works
Dubé‐Zinatelli, E., Anderson, F., & Ismail, N. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101203 · Cited by 28 · see citing works
Bahadur, A., Verma, N., Mundhra, R., Chawla, L., Ajmani, M., Sri, M. S., & Arora, S. (2021) · Cureus · doi:10.7759/cureus.16047 · Cited by 27 · see citing works
Wen, X., Wang, L., & Bai, E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1370578 · Cited by 25 · see citing works
Venkatesh, V. S., Grossmann, M., Zajac, J. D., & Davey, R. A. (2022) · Obesity Reviews · doi:10.1111/obr.13429 · Cited by 22 · see citing works
Jin, R., Chen, A., Ye, Y., Ren, Y., Lu, J., Xuan, F., & Zhou, W. (2024) · Molecular Reproduction and Development · doi:10.1002/mrd.23768 · Cited by 22 · see citing works
Dai, M., Yang, X., Yu, Y., & Pan, W. X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827486 · Cited by 22 · see citing works
PCOS phenotype focus: phenotype D under the magnifying glass
Myers, S. H., Oliva, M. M., Nordio, M., & Unfer, V. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07408-2 · Cited by 22 · see citing works
Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome
Mansour, A., Noori, M., Hakemi, M. S., Haghgooyan, Z., Mohajeri‐Tehrani, M. R., Mirahmad, M., & Sajjadi‐Jazi, S. M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01733-y · Cited by 21 · see citing works
Mansour, A., Taheri, A. P. H., Moradi, B., Mohajeri‐Tehrani, M. R., Qorbani, M., Pashakolaee, S. G., Sanginabadi, M., & Sajjadi‐Jazi, S. M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01224-y · Cited by 20 · see citing works
Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population
Mansour, A., Mirahmad, M., Mohajeri‐Tehrani, M. R., Jamalizadeh, M., Hosseinimousa, S., Rashidi, F., Asili, P., & Sajjadi‐Jazi, S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-37513-2 · Cited by 16 · see citing works
Özay, A. C., Özay, Ö. E., & Gülekli, B. (2020) · Ginekologia Polska · doi:10.5603/gp.a2020.0122 · Cited by 16 · see citing works
Body Fat Distribution and Female Infertility: a Cross-Sectional Analysis Among US Women
Wang, X., Zhu, R., Han, H., & 梅津, 敬. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01280-2 · Cited by 14 · see citing works
Adamska, A., Popławska‐Kita, A., Siewko, K., Łebkowska, A., Krentowska, A., Buczyńska, A., Popławski, Ł., Szumowski, P., Szelachowska, M., Kretowski, A. J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657752 · Cited by 14 · see citing works
Self-citationBody Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
Bizoń, A., Płaczkowska, S., Niepsuj, J., Czwojdzińska, M., Leśniewski, M., Nowak, A., Pluta, D., Madej, P., Piwowar, A., & Franik, G. (2021) · Nutrients · doi:10.3390/nu13124217 · Cited by 13 · see citing works
Ivatt, L., Paul, M. A., Miguelez-Crespo, A., Hadoke, P. W. F., Bailey, M. A., Morgan, R., & Nixon, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02596-w · Cited by 8 · see citing works
Liu, Z., Song, Y., Xu, Y., Wang, J., Hu, H.-Y., & Weng, Y. (2020) · Medicine · doi:10.1097/md.0000000000023811 · Cited by 8 · see citing works
Mehra, T., Sharma, S., Zahra, T., Jangir, S., & Gupta, B. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01042-y · Cited by 8 · see citing works
Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., Terra, C., Salgado, Â. A., & Kraemer‐Aguiar, L. G. (2024) · Endocrine · doi:10.1007/s12020-024-04077-8 · Cited by 9 · see citing works
Yang, Y., Zhang, H., Huang, B., Lu, Y., Fukuzawa, I., Yang, S.-H., Zhou, L.-F., Luo, L., Wang, C., Ding, N., et al. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01541-x · Cited by 8 · see citing works
Zhang, H., Yang, Y., Zhao, Y., Shi, L., Jiao, P., Yang, Y., Jin, Y., Zeng, L., Zhang, H., Chen, M., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2373199 · Cited by 6 · see citing works
Evaluating spironolactone monotherapy against combined treatment with metformin in rat PCOS model
Bashir, S. M., Ali, S. I., Rather, M. A., Sheikh, W. M., Singh, H., Nabi, S. U., Ganie, M. A., Shafi, M., Shah, M. Z. U. H., Bhat, J. I., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177516 · Cited by 4 · see citing works
Татарчук, Т. Ф., Педаченко, Н. Ю., Косей, Н. В., Malysheva, I., Snizhko, T. B., Козуб, Т., Zolotarevska, O., Kosianenko, S., & Tutchenko, T. М. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.011 · Cited by 3 · see citing works
Morales-Esponda, M., Aguilar, R. D. L. S., Villanueva-Rodríguez, R., Oliva, L. D. S., Aguilar-Salinas, C. A., Chirinos, M., & Larrea, F. (2025) · Revista de investigaci�n Cl�nica · doi:10.1016/j.ric.2025.100008 · Cited by 2 · see citing works
Wang, L., Liu, J., Wang, J., Liu, P., Zhao, Q. P., Wang, Y., Zhao, H., Zhu, X. Y., Liu, S., & Zhang, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1642112 · Cited by 2 · see citing works
Russo, M., Porcaro, G., Aragona, C., Bilotta, G., Liberto, M. D., & Unfer, V. (2025) · Nutrients · doi:10.3390/nu17233695 · Cited by 2 · see citing works
Polak, A. M., Łebkowska, A., Krentowska, A., Buczyńska, A., Adamski, M., Kretowski, A. J., Kowalska, I., & Adamska, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144610 · Cited by 2 · see citing works
Self-citationFalh, Z. G., Saleh, B. O. M., & Al-Naddawi, A. M. (2024) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.13.1.106 · Cited by 2 · see citing works
Insulin resistance and dysglycaemia in polycystic ovary syndrome patients
Dere, K. A. L., Prisca, D. A., Menin, M. M., Coulibaly, D., & Tiahou, G. G. (2021) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2020.101 · Cited by 2 · see citing works
C-peptide in polycystic ovary syndrome
Gharebagh, F. M., Najafi, S., Zeinalpour, A., Pirouzmand, R. S., Ghasemnejad‐Berenji, H., & Taheri‐Anganeh, M. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120829 · Cited by 1 · see citing works
Dysregulation of Endothelial cell markers in polycystic ovary syndrome
Borde, P., Niinuma, S. A., Habib, H., Takemoto, A. S.-N., Nandakumar, M., Sathyapalan, T., Butler, A. E., & Atkin, S. L. (2026) · Scientific Reports · doi:10.1038/s41598-026-40533-3 · Cited by 2 · see citing works
Gong, Z., Li, D., Li, X., Tian, J., Guo, J., Zhao, Y., Lu, Y., Gao, S., & Li, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1753316 · Cited by 1 · see citing works
Ивановна, А. Е., Yarmolinskaya, M. I., & Osinovskaya, N. S. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd611015 · Cited by 1 · see citing works
Neuregulin 4 in Polycystic Ovarian Syndrome (PCOS) Phenotypes: A Key Role or Standby
Abbood, A. H., Hameed, R. M., & Safi, W. G. A. (2023) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.12.3.359 · Cited by 1 · see citing works
Villarroel, C., Henríquez, S., Kohen, P., & Devoto, L. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_7 · Cited by 1 · see citing works
Clinical and laboratory features in women with different phenotypes of polycystic ovary syndrome
Safari, A., Mosadeghkhah, A., & Khameneie, M. K. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05124-7
de Magalhães, A. C. L., Carvalho, V. F., da Cruz, S. P., & Ramalho, A. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04342
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
Манжалій, Е., Татарчук, Т. Ф., Tutchenko, T. М., Косей, Н. В., & Mnevets, R. O. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.70.40-45
Tsutsumi, T., Komai, S., Miyazaki, A., & Tsuchiya, K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1878776
Yousuf, S. D., Ahmed, W., Qadir, A., Rehman, N. U., Islam, K. U., & Ganie, M. A. (2026) · Cureus · doi:10.7759/cureus.113105
- Authors
- Polak, A. M., Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Adamski, M., & Kowalska, I.
- Affiliations
- Medical University of Białystok (PL)
- Bialystok University of Technology (PL)
- Corresponding author
- Adamska, Agnieszka
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-03-09
- Volume
- 9
- Issue
- 3
- Pages
- 732
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7141288
- OpenAlex
- W3010060426
- Cited by
- 48
- References
- 34
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 11 · 2022: 6 · 2021: 8 · 2020: 2
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Medical University of Białystok (OP DEP 2007-2013, Priority Axis I.3, contrast No POPW.01.03.00-20-008/09.)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, PCOS phenotypes, body composition, insulin resistance, hyperandrogenemia, free androgen index, visceral adipose tissue, android/gynoid fat ratio, androstenedione, dehydroepiandrosterone sulfate, testosterone, Rotterdam criteria, HOMA-IR, body fat distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
